CE Mark for BioMimics 3D stent

HORSHAM, West Sussex, UK – Veryan Medical Limited said it has received CE Mark approval for its BioMimics 3D stent, designed for treatment of the superficial femoral and proximal popliteal (femoropopliteal) arteries of the leg.

The device features a unique three-dimensional design that mimics the natural helical geometry of the vascular system for improved blood flow in the stented segment. This may confer a protective effect and enhance biomechanical performance, such that kinking, deformation, and consequential vessel trauma during leg flexion may be reduced.

The approval was based on meeting the primary endpoints of the MIMICS study that compared the safety and efficacy of the device with a standard nitinol stent in patients with peripheral artery disease undergoing femoropopliteal artery intervention.

Following the approval by European regulators, Veryan is currently preparing the commercialisation of the BioMimics 3D stent system in Europe and other regions covered by the approval.